Erasca Inc (ERAS)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current ERAS market cap is 413.6M. The company's latest EPS is USD -0.5706 and P/E is -2.59.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -33.87M | -38.85M | -67.78M | -37.24M | -35.71M |
| Net Income | -29.7M | -35.02M | -63.2M | -31.2M | -32.23M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -109.25M | -124.88M | -247.45M | -141.53M | -179.59M |
| Net Income | -101.66M | -122.76M | -242.81M | -125.04M | -161.65M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 395.3M | 370.02M | 525.74M | 528.9M | 502.53M |
| Total Liabilities | 78.61M | 81.61M | 74.66M | 78.85M | 79.03M |
| Total Equity | 316.69M | 288.41M | 451.09M | 450.04M | 423.5M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 124.83M | 501.42M | 514.91M | 395.3M | 502.53M |
| Total Liabilities | 17.4M | 44.89M | 103.06M | 78.61M | 79.03M |
| Total Equity | -113.98M | 456.53M | 411.85M | 316.69M | 423.5M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -101.22M | -33.25M | -62.43M | -84.85M | -109.42M |
| Investing | -91.22M | 9.97M | -76.64M | -179.23M | -156.62M |
| Financing | 1.3M | 6.93M | 218.8M | 239.9M | 240.7M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -32.69M | -79.6M | -103.26M | -101.22M | -109.42M |
| Investing | -71.2M | -64.59M | -71.08M | -91.22M | -156.62M |
| Financing | 139.99M | 439.4M | 98.08M | 1.3M | 240.7M |
| Market Cap | 413.6M |
| Price to Earnings Ratio | -2.59 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.19 |
| Price to Book Ratio | 0.99 |
| Dividend Yield | - |
| Shares Outstanding | 283.29M |
| Average Volume (1 week) | 1.27M |
| Average Volume (1 Month) | 1.6M |
| 52 Week Change | -34.53% |
| 52 Week High | 3.45 |
| 52 Week Low | 1.01 |
| Spread (Intraday) | 0.16 (10%) |
| Company Name | Erasca Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.erasca.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
